For comparison, 3 mg/day of liraglutide resulted in -9% weight loss from baseline [11]
REDEFINE clinical trial program: Safety and efficacy data
Here are the most common concerns and evidence-based answers
Erik M, Fredrik N, Cecilia ML, Niklas B, Marco Z, Emma N, et al
Wikipedia contributors Cerebrolysin (composition, development code FPF-1070, countries of use)
doi: 10.3389/fphar.2024.1392325 Received 27 February 2024 Accepted 13 August 2024 Published 23 August 2024 Volume 15 - 2024 Edited by Josipa Vlainic, Rudjer Boskovic Institute, Croatia Reviewed by Arindam Ghosh Mazumder, Baylor College of Medicine, United States Katarzyna Stachowicz, Polish Academy of Sciences, Poland Updates Copyright 2024 Hakimi Naeini, Rajabi-Maham, Azizi and Hosseini